“Compare suppliers above. Sort by price, purity, or supplier rating. Add lines from any vendor to one cart.”— PEPVERA · marketplace


Pentadeca Arginate
BPC-157 evolution.
- Sizes available
- 2mg · 5mg
- Tested by
- self-test (ISO 17025 lab)
- Purity
- 99.39192% (HPLC)
- Batch ID
- VER-PEN-2
- Made
- April 2026
- Expires
- April 2027
- Suppliers selling this
- 10
The molecule, plainly.
Mechanism, target dose, ramp, and risks — sourced from the supplier's documented protocol.
- Mechanism
- Stable BPC-157 analogue with arginate salt. Improved oral bioavailability.
- Target dose
- 500 mcg / day.
- Ramp
- 6-8 weeks.
- Risks
- Newer compound, less long-term data.
Draw 20 units.
0.2 mg = 0.20 mL at 1.00 mg/mL. 10.0 doses per vial.
Week 1
500 mcg / day.
Begin near site
Week 2–4
500 mcg / day.
Daily, rotate
Week 5–6
500 mcg / day.
Taper option
Week 7+
Maintenance
As needed
Sourced from public discussion. Anonymized. Original wording preserved. Customers may submit a Field Report after delivery; curated entries appear above with the verified ordinal.
Verified by Janoshik
ISO 17025
Independent third-party HPLC and mass spectrometry on every batch.
Refund on unopened
thirty days
Full refund within thirty days on any unopened vial. No questions.
Replacement on damage
cold-chain
Insulated express. If a vial arrives warm or broken, full replacement.
Direct from foundry. Slower than domestic resellers; consistency is the trade. Insulated packaging, tracked from departure to doorstep. Replacement issued on damage.
Stable BPC-157 analogue with arginate salt. Improved oral bioavailability.
Research-grade peptide. Sold for laboratory use only — not for human consumption.
repair · IX · Verified Peptides
Pentadeca Arginate · 2mg